Stoke Therapeutics Inc (STOK)
US$ 9.76-1.21%
Price Chart
Key Statistics
Market Cap
$ 647.52M
P/E Ratio
14.46
Revenue (TTM)
$ 190.91M
Volume
580.62K
52W High
$ 16.15
52W Low
$ 5.35
Dividend Yield
0.00%
Beta
1.10
Technicals
50-Day MA
10.59
200-Day MA
10.5216
52 Week High
16.15
52 Week Low
5.35
About STOK
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.
Employees
128
Headquarters
Bedford, MA
CEO
Dr. Arthur O. Tzianabos Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg